At a glance
- Originator Pfizer
- Class Antihypertensives
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Hypertension
Most Recent Events
- 07 Apr 2000 Discontinued-Unspecified Phase in Angina pectoris in United Kingdom (Unknown route)
- 07 Apr 2000 Discontinued-Unspecified Phase in Hypertension in United Kingdom (Unknown route)
- 13 Jul 1995 No-Development-Reported for Angina pectoris in United Kingdom (Unknown route)